Grove AD - Search Results

1

Differential protection by rat UDP-glucuronosyltransferase 1A7 against Benzo[a]pyrene-3,6-quinone- versus Benzo[a]pyrene-induced cytotoxic effects in human lymphoblastoid cells.

Grove AD, Llewellyn GC, Kessler FK, White KL Jr, Crespi CL, Ritter JK. Grove AD, et al. Toxicol Appl Pharmacol. 2000 Jan 1;162(1):34-43. doi: 10.1006/taap.1999.8815. Toxicol Appl Pharmacol. 2000. PMID: 10631125

2

Identification of a rat oltipraz-inducible UDP-glucuronosyltransferase (UGT1A7) with activity towards benzo(a)pyrene-7,8-dihydrodiol.

Grove AD, Kessler FK, Metz RP, Ritter JK. Grove AD, et al. J Biol Chem. 1997 Jan 17;272(3):1621-7. doi: 10.1074/jbc.272.3.1621. J Biol Chem. 1997. PMID: 8999837 Free article.

3

Mono- and Diglucuronide formation from benzo[a]pyrene and chrysene diphenols by AHH-1 cell-expressed UDP-glucuronosyltransferase UGT1A7.

Bock KW, Raschko FT, Gschaidmeier H, Seidel A, Oesch F, Grove AD, Ritter JK. Bock KW, et al. Among authors: grove ad. Biochem Pharmacol. 1999 Mar 15;57(6):653-6. doi: 10.1016/s0006-2952(98)00337-2. Biochem Pharmacol. 1999. PMID: 10037450

4

Expression and inducibility of the human bilirubin UDP-glucuronosyltransferase UGT1A1 in liver and cultured primary hepatocytes: evidence for both genetic and environmental influences.

Ritter JK, Kessler FK, Thompson MT, Grove AD, Auyeung DJ, Fisher RA. Ritter JK, et al. Among authors: grove ad. Hepatology. 1999 Aug;30(2):476-84. doi: 10.1002/hep.510300205. Hepatology. 1999. PMID: 10421657

5

Pharmacological effects of epibatidine optical enantiomers.

Damaj MI, Creasy KR, Grove AD, Rosecrans JA, Martin BR. Damaj MI, et al. Among authors: grove ad. Brain Res. 1994 Nov 21;664(1-2):34-40. doi: 10.1016/0006-8993(94)91950-x. Brain Res. 1994. PMID: 7895043

6

Paternal Hemizygosity in 11p15 in Mole-like Conceptuses: Two Case Reports.

Sunde L, Lund H, J Sebire N, Grove A, Fisher RA, Niemann I, Kjeldsen E, Andreasen L, Hansen ES, Bojesen A, Bolund L, Nyegaard M. Sunde L, et al. Medicine (Baltimore). 2015 Nov;94(44):e1776. doi: 10.1097/MD.0000000000001776. Medicine (Baltimore). 2015. PMID: 26554776 Free PMC article.

7

A major imprinted gene involved in hydatidiform mole is not located in 2q31.2-qter or 5q34-qter.

Lund H, Nyegaard M, Svarrer T, Grove A, Sunde L. Lund H, et al. Gene. 2012 Apr 15;497(2):280-4. doi: 10.1016/j.gene.2012.01.093. Epub 2012 Feb 9. Gene. 2012. PMID: 22336177

8

p57 in Hydatidiform Moles: Evaluation of Antibodies and Expression in Various Cell Types.

Lund H, Nielsen S, Grove A, Vyberg M, Sunde L. Lund H, et al. Appl Immunohistochem Mol Morphol. 2020 Oct;28(9):694-701. doi: 10.1097/PAI.0000000000000807. Appl Immunohistochem Mol Morphol. 2020. PMID: 31567274 Free PMC article.

9

Decreasing incidence of registered hydatidiform moles in Denmark 1999-2014.

Lund H, Vyberg M, Eriksen HH, Grove A, Jensen AØ, Sunde L. Lund H, et al. Sci Rep. 2020 Oct 12;10(1):17041. doi: 10.1038/s41598-020-73921-4. Sci Rep. 2020. PMID: 33046739 Free PMC article.

10

Hydatidiform mole: validity of the registration in the Danish National Patient Registry, the Danish Cancer Registry, and the Danish Pathology Registry 1999-2009.

Lund H, Vyberg M, Eriksen HH, Grove A, Jensen AØ, Sunde L. Lund H, et al. Clin Epidemiol. 2018 Sep 18;10:1223-1231. doi: 10.2147/CLEP.S169657. eCollection 2018. Clin Epidemiol. 2018. PMID: 30271218 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

38 results

Search Page